TB Research

A case of recurrent erythema induratum of Bazin in a patient with myelodysplastic syndrome

Noro K, Murase C, Fukaura R, Watanabe N, Sunohara K, Ishii N, Yamazaki M, Akiyama M

Nagoya journal of medical science · 2024-05

Abstract

We describe a case of erythema induratum of Bazin (EIB) that presented recurrently on the extremities during treatment with anti-tuberculosis medications. The anti-tuberculosis medications were effective, so they were continued despite the occurrence of the EIB lesions, and those lesions disappeared 5 months after first appearing. EIB is currently considered a multifactorial disorder with many different causes, with tuberculosis being an example, and it is thought to be a hypersensitive immune response to Mycobacterium tuberculosis . The clinical manifestations may fluctuate depending on the immune response of the host. Our patient was affected with myelodysplastic syndrome, and we believe that this was a major factor that interfered with a normal immune response. This case illustrates the importance of providing intensive anti-tuberculosis treatment from the start, and in cases where EIB co-presents, to continue this treatment until the end, in order to prevent relapse.

MeSH terms

  • Humans
  • Erythema Induratum
  • Myelodysplastic Syndromes
  • Recurrence
  • Antitubercular Agents
  • Aged
  • Female
  • Male